← Back to Search

Sleep Restriction for Sleep (SASE2 Trial)

N/A

Waitlist Available

Led By Aric A Prather, PhD

Research Sponsored by University of California, San Francisco

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to post-rejection task, anticipated average of 42 minutes

Awards & highlights

SASE2 Trial Summary

This trial will test how sleep deprivation affects a person's ability to discriminate, as well as their cardiovascular health. The study will specifically focus on African Americans to see how they are affected.

Who is the study for?

This study is for English-speaking African Americans aged 18-64 who usually sleep between 10 PM and 12 AM, with a normal sleep duration of 6.5 to 8.5 hours confirmed by actigraphy and diary. Excluded are those over age 64, BMI of 40+, with clinical sleep disorders or on medications affecting sleep/cardiovascular function.Check my eligibility

What is being tested?

The trial examines how restricted sleep affects perceptions of discrimination and cardiovascular health in African Americans. It will also explore factors that might influence the link between racial discrimination experiences and actual sleep patterns.See study design

What are the potential side effects?

Since this trial involves sleep restriction, potential side effects may include increased fatigue, irritability, difficulty concentrating, mood changes, and possibly elevated blood pressure due to stress.

SASE2 Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to post-rejection task, anticipated average of 42 minutes

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to post-rejection task, anticipated average of 42 minutes

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to post-rejection task, anticipated average of 42 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in blood pressure post-rejection

Secondary outcome measures

Change in affect

Change in heart rate variability (HRV) in response to rejection task

Change in pre-ejection period (PEP) in response to rejection task

+2 more

SASE2 Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Total Sleep RestrictionExperimental Treatment1 Intervention

Participants will experience a night of total sleep restriction and then undergo a social-rejection task in the morning.

Group II: Normal SleepActive Control1 Intervention

Participants will sleep in the laboratory for 8 hours and then undergo the same social-rejection paradigm as the experimental group to serve as a control comparison.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Sleep Restriction

2016

N/A

~470

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor

2,507 Previous Clinical Trials

15,238,490 Total Patients Enrolled

6 Trials studying Sleep

440 Patients Enrolled for Sleep

National Heart, Lung, and Blood Institute (NHLBI)NIH

3,841 Previous Clinical Trials

47,814,028 Total Patients Enrolled

31 Trials studying Sleep

56,996 Patients Enrolled for Sleep

Aric A Prather, PhDPrincipal InvestigatorUniversity of California, San Francisco

2 Previous Clinical Trials

1,597 Total Patients Enrolled

1 Trials studying Sleep

139 Patients Enrolled for Sleep

Media Library

Sleep Restriction 2023 Treatment Timeline for Medical Study. Trial Name: NCT05166590 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the maximum patient capacity for this trial?

"Affirmative. Based on the listed information hosted on clinicaltrials.gov, this medical study is actively recruiting participants. This trial was first posted June 1st 2021 and last modified July 28th 2022 - with a goal to recruit 80 people from one site."

Answered by AI

Is this research open to participants of a more senior age demographic?

"As stated in the criteria, this study only recruits patients aged 18 to 64. Those who are below or above these age brackets have 36 and 168 trials respectively to choose from."

Answered by AI

What specific criteria must be met in order to qualify for this medical experiment?

"Eligibility for this medical study requires that participants must be of nocturnal disposition and between the ages 18 to 64. In total, 80 applicants will be accepted."

Answered by AI

Are there still vacancies in this trial that prospective participants can take advantage of?

"In accordance with clinicaltrials.gov, this medical trial is actively seeking applicants. It was initially posted on June 1st 2021 and it has been recently updated on July 28th 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Sleep and Social Experiences Study 2

2021. "Sleep and Social Experiences Study 2". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05166590.

All > Sleep